Abstract
No direct evidence for a link between quinagolide and valvulopathy was identified; however, cabergoline (another dopamine agonist) has been associated with valvulopathy. More specific research is needed on quinagolide.
Keywords
- Cardiac Valve Diseases and Treatments
- quinagolide
- valvulopathy
- dopamine agonists
- cabergoline
- adverse drug reactions
- Open access
Source
Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
At a glance
- Journal
- Zenodo